We want to see that investment in quality translate directly into impeccable data for you
As of July 2026, Ro has fully exited compounded GLP-1s and sells only FDA-approved branded medication: Wegovy oral pill at $149/month for the first month, rising to $199$299/month at higher ongoing doses
Zepbound was approved a year and a half later, in November 2023, for chronic weight management in adults with obesity as well as those who are overweight and have at least one weight-related condition (like high blood pressure or high cholesterol)
Appl Biochem Biotechnol 195:52535266 Yoshida E, Suzuki T, Morita M, Taguchi K, Tsuchida K, Motohashi H, Doita M, Yamamoto M (2018) Hyperactivation of nrf2 leads to hypoplasia of bone in vivo
As per FDA approval in 2021, it's indicated for chronic weight management in adults with obesity or overweight with at least one weight-related condition such as high blood pressure, type 2 diabetes mellitus or high cholesterol (hyperlipidemia)
Conservative initial dosing allows researchers to assess individual response patterns while minimizing the risk of adverse reactions
